Gamida Cell GMDA Stock
Gamida Cell Price Chart
Gamida Cell GMDA Financial and Trading Overview
| Gamida Cell stock price | 0.03 USD |
| Previous Close | 2.08 USD |
| Open | 2.08 USD |
| Bid | 0 USD x 3000 |
| Ask | 0 USD x 4000 |
| Day's Range | 1.95 - 2.1 USD |
| 52 Week Range | 0.56 - 3.66 USD |
| Volume | 2.12M USD |
| Avg. Volume | 5.45M USD |
| Market Cap | 206.95M USD |
| Beta (5Y Monthly) | 1.605396 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.8 USD |
GMDA Valuation Measures
| Enterprise Value | 268.56M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.3555555 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.59 |
Trading Information
Gamida Cell Stock Price History
| Beta (5Y Monthly) | 1.605396 |
| 52-Week Change | 2.61% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.66 USD |
| 52 Week Low | 0.56 USD |
| 50-Day Moving Average | 1.73 USD |
| 200-Day Moving Average | 1.66 USD |
GMDA Share Statistics
| Avg. Volume (3 month) | 5.45M USD |
| Avg. Daily Volume (10-Days) | 2.14M USD |
| Shares Outstanding | 105.59M |
| Float | 84.61M |
| Short Ratio | 0.86 |
| % Held by Insiders | 20.73% |
| % Held by Institutions | 32.89% |
| Shares Short | 3.18M |
| Short % of Float | 3.32% |
| Short % of Shares Outstanding | 3.00% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -40.95% |
| Return on Equity (ttm) | -1666.049% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -74816000 USD |
| Net Income Avi to Common (ttm) | -80112000 USD |
| Diluted EPS (ttm) | -1.23 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 46.76M USD |
| Total Cash Per Share (mrq) | 0.44 USD |
| Total Debt (mrq) | 95.7M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.163 |
| Book Value Per Share (mrq) | -0.187 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -66979000 USD |
| Levered Free Cash Flow (ttm) | -43567000 USD |
Profile of Gamida Cell
| Country | United States |
| State | N/A |
| City | Jerusalem |
| Address | 5 Nahum Heftsadie Street |
| ZIP | 91340 |
| Phone | 972 2 659 5666 |
| Website | https://www.gamida-cell.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 143 |
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with hematologic malignancies, as well as in Phase II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, an investigational NK cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was incorporated in 1998 and is headquartered in Jerusalem, Israel.
Q&A For Gamida Cell Stock
What is a current GMDA stock price?
Gamida Cell GMDA stock price today per share is 0.03 USD.
How to purchase Gamida Cell stock?
You can buy GMDA shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Gamida Cell?
The stock symbol or ticker of Gamida Cell is GMDA.
Which industry does the Gamida Cell company belong to?
The Gamida Cell industry is Biotechnology.
How many shares does Gamida Cell have in circulation?
The max supply of Gamida Cell shares is 0.
What is Gamida Cell Price to Earnings Ratio (PE Ratio)?
Gamida Cell PE Ratio is now.
What was Gamida Cell earnings per share over the trailing 12 months (TTM)?
Gamida Cell EPS is 0 USD over the trailing 12 months.
Which sector does the Gamida Cell company belong to?
The Gamida Cell sector is Healthcare.
Gamida Cell GMDA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16708.05 USD — |
+2.5
|
7.57B USD — | 16642.66 USD — | 17029.86 USD — | — - | 7.57B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4124.19 USD — |
+3.5
|
— — | 3927.42 USD — | 4124.19 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 1839.98 USD — |
+3.19
|
— — | 1832.76 USD — | 1881.09 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4116.15 USD — |
+1.68
|
— — | 4101.26 USD — | 4187.02 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 911.61 USD — |
+1.7
|
— — | 909.68 USD — | 929.8 USD — | — - | — — |
- {{ link.label }} {{link}}